Highlights Edwards Lifesciences Corporation Wiener Boerse

Equities

EWLS

US28176E1082

Real-time Estimate Tradegate Other stock markets 03:50:56 2024-05-23 am EDT			5-day change	1st Jan Change
83.38 ^EUR	+1.55%		+2.80%	+18.33%

May. 22	Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	MT
May. 14	Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edwards Lifesciences Faces EU Antitrust Complaint By Meril	May. 13	MT
Edwards Lifesciences hit with Meril's EU antitrust complaint	May. 13	RE
Edwards Lifesciences Corporation Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability	May. 08	CI
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Edwards Lifesciences Q1 Adjusted Earnings, Net Sales Increase, Q2 Guidance Set	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Posts Q1 EPS $0.66, vs. Street Est of $0.64	Apr. 25	MT
Earnings Flash (EW) EDWARDS LIFESCIENCES CORPORATION Reports Q1 Revenue $1.6B, vs. Street Est of $1.57B	Apr. 25	MT
Edwards Lifesciences Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Edwards Lifesciences Corporation Revises Earnings Guidance for the Full Year 2024	Apr. 25	CI
Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024	Apr. 25	CI
Edwards Lifesciences Corporation: The story continues	Apr. 23
Edwards Lifesciences Announces the Release of Data from the Hudle Study	Apr. 07	CI
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	Mar. 21	MT
Sector Update: Health Care Stocks Higher in Afternoon Trading	Mar. 21	MT
Edwards Lifesciences Announces Large, Real-World Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR	Mar. 11	CI
US FDA staff raises no new concerns about Abbott's heart device	Feb. 09	RE
Fed officials fail to convince investors, who are focused on earnings	Feb. 07
Edwards Lifesciences beats quarterly estimates on strong heart device sales	Feb. 06	RE
Edwards Lifesciences' Q4 Adjusted Earnings Unchanged, Sales Rise; Q1, 2024 Guidance Set	Feb. 06	MT
Tranche Update on Edwards Lifesciences Corporation (NYSE:EW)'s Equity Buyback Plan announced on July 28, 2022.	Feb. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am EDT